When an Rhesus-negative (Rh - ) person receives blood from an Rhesus-positive (Rh + ) person, the reason behind the person to have transfusion reaction in the second blood transfusion and not during the first transfusion reaction.. Introduction: The Rh blood group contains the Rh antigen on the red blood cells (RBCs). It is named so because one of the eight Rh antigens (agglutinogen D) was originally identified in Rhesus monkeys. This antigen was originally discovered in Rhesus monkeys and later revealed in the humans. A person who is Rh + contains Rh antigen, whereas the person who lacks the Rh antigen is known as Rh - .

Question

Want to see the full answer?

Answer 1

Question

Chapter 10, Problem 25SAE

Summary Introduction

To review:

When an Rhesus-negative (Rh^-) person receives blood from an Rhesus-positive (Rh⁺) person, the reason behind the person to have transfusion reaction in the second blood transfusion and not during the first transfusion reaction..

Introduction:

The Rh blood group contains the Rh antigen on the red blood cells (RBCs). It is named so because one of the eight Rh antigens (agglutinogen D) was originally identified in Rhesus monkeys. This antigen was originally discovered in Rhesus monkeys and later revealed in the humans. A person who is Rh⁺ contains Rh antigen, whereas the person who lacks the Rh antigen is known as Rh^-.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

According to a recent study, 1 out of 50,000 people will be diagnosed with cystic fibrosis. Cystic fibrosis can be caused by a mutant form of the CFTR gene (dominant gene symbol is F and mutant is f). A. Using the rate of incidence above, what is the frequency of carriers of the cystic fibrosis allele for CFTR in the US? (3 pts) B. In a clinical study, 400 people from the population mentioned in (A.) were genotyped for BRCA1 Listed below are the results. Are these results in Hardy- Weinberg equilibrium? Use Chi Square to show whether or not they are. (3 pts) BRCA1 genotype # of women 390 BB Bb bb 10 0 12pt Paragraph L BIUAV V T² v V

Outline a method for using apomixis to maintain feminized CannabisAssume apomixis is controlled by a single dominant gene. You can choose the type of apomixis: obligate or facultative, gametophytic or sporophytic. Discuss advantages and disadvantages of your proposed method.

Kinetics: One-Compartment First-Order Absorption 1. In vivo testing provides valuable insight into a drug’s kinetics. Assessing drug kinetics following multiple routes of administration provides greater insight than a single route of administration alone. The following data was collected in 250-g rats following bolus IV, oral (PO), and intraperitoneal (ip) administration. Using this data and set of graphs, determine:(calculate for each variable) (a) k, C0, V, and AUC* for the bolus iv data (b) k, ka, B1, and AUC* for the po data c) k, ka, B1, and AUC* for the ip data (d) relative bioavailability for po vs ip, Fpo/Fip (e)absolute ip bioavailability, Fip (f) absolute po bioavailability, Fpo